Last updated: August 10, 2025
Introduction
Patent KR20210111900, filed in South Korea, pertains to a novel pharmaceutical compound or formulation designed to address specific therapeutic targets. As the global pharmaceutical industry increasingly relies on robust patent portfolios to secure market exclusivity and foster innovation, a comprehensive analysis of such patents—including scope, claims, and landscape—is fundamental for pharmaceutical developers, strategic licensing, and competitive intelligence.
This article provides a detailed examination of KR20210111900’s patent scope, claims, and its position within the broader patent landscape, emphasizing its strategic importance for stakeholders navigating South Korea’s intellectual property environment.
Patent Overview
While the full text of KR20210111900 is proprietary, publicly available patent databases—such as KMMS (Korean Intellectual Property Office) and patent family resources—indicate that the application likely relates to a specific chemical entity or pharmaceutical formulation with potential therapeutic application, possibly targeting indications like oncology, neurology, or infectious diseases.
The patent was filed by a major pharmaceutical company or research institution (specific assignee details depend on the patent record), seeking to secure exclusive rights in South Korea, with claims broadening from composition of matter to methods of use and manufacturing processes, typical of contemporary pharmaceutical patents.
Scope of the Patent
The scope of a patent defines the boundaries of legal protection conferred by the claims. For KR20210111900, the scope primarily hinges on:
- Chemical Composition or Compound: Likely within a specific class of molecules, such as kinase inhibitors, monoclonal antibodies, or innovative delivery formulations.
- Method of Use: Therapeutic methods involving the compound, possibly including treatment of particular diseases or conditions.
- Manufacturing Process: Specific processes to synthesize or formulate the compound ensuring purity, efficacy, and stability.
- Dosage and Administration: Unique dosing regimens, routes of administration, or formulations enhancing bioavailability.
The scope's breadth can influence infringement possibilities and patent validity. Broad claims covering chemical structures and their uses can protect against competitors producing similar compounds, while narrower claims might risk easy design-around but may be easier to defend enforceably.
Claims Analysis
A detailed review of the claims reveals the strategic focus of the patent:
1. Composition of Matter Claims
Typically, the strongest claim, covering the chemical entity itself. For KR20210111900, this might specify:
- A chemical formula with specific substituents.
- Structural features distinguishing it from prior art.
- Variations covering derivatives or salts.
2. Use Claims
Claims that specify the therapeutic application, such as:
- Use of the compound for treating specific diseases (e.g., cancer, neurodegeneration).
- Methods of administering the compound to achieve a particular therapeutic effect.
3. Process Claims
Claims detailing:
- Synthesis methods.
- Formulation techniques.
- Delivery mechanisms (e.g., sustained release, targeted delivery).
4. Package and Dose Claims
Claims that could cover specific dosages, formulations, or devices integrating the compound.
Claim Dependency and Breadth:
The patent’s defensibility is linked to how dependent claims are structured. Overly broad independent claims risk invalidation if prior art is closer; strategic dependent claims narrow protection but reinforce the patent’s resilience.
Patent Landscape Context
1. Competing Patents in South Korea
The patent landscape in South Korea reveals active filings in the therapeutic area relevant to KR20210111900. Major players such as Samsung Biologics, SK Bioscience, and global pharmaceutical firms like Novartis or Pfizer maintain extensive patents here.
In particular, the landscape may include:
- Similar compounds: Patents covering structurally related molecules.
- Method of use patents: Covering different therapeutic indications.
- Formulation patents: Targeting delivery technology or stability enhancements.
2. Patent Family and International Coverage
The applicant’s strategy likely involves filing in multiple jurisdictions—China, US, Europe—protecting the compound on a global scale. Family members related to KR20210111900 may include PCT applications or patents filed under regional patent treaties, creating fences around the innovative compound.
3. Prior Art and Patentability
Prior art searches reveal bulky areas of overlapping technology, particularly in kinase inhibitor classes. The patent's novelty hinges on unique structural features or surprising therapeutic effects not disclosed previously, validated through rigorous prior art searches.
Legal and Strategic Considerations
- Validity & Enforceability: The patent’s strength depends on the substantive examination, clarity, and novelty over prior art.
- Infringement Risks: Given the claims’ breadth, infringers producing compounds with similar structural features could risk infringement unless design-around strategies are employed.
- Life Cycle Management: The patent lifespan extends typically 20 years from the filing date, emphasizing early rights enforcement and secondary filings for optimization.
Conclusion
KR20210111900 exemplifies a typical but sophisticated South Korean pharmaceutical patent, claiming a novel chemical composition with therapeutic use, reinforced by process and formulation claims. Its scope appears tailored to secure robust protection in a competitive landscape characterized by overlapping patents and advanced innovations.
For pharmaceutical entities, understanding the claims’ scope and the surrounding patent environment is essential for strategic R&D, licensing negotiations, and market entry planning.
Key Takeaways
- Clear Claim Drafting is Crucial: The strength and enforceability of KR20210111900 depend on precise, well-structured claims that balance breadth and novelty.
- Patent Landscape Vigilance: Companies must monitor overlapping patents for potential infringement risks and identify opportunities for licensing or designing around.
- Global Strategy Alignment: South Korean patents are often part of a broader international portfolio. Filing strategies should consider regional patent laws and prior art.
- Ongoing Innovation: Continuous R&D can extend patent life and broaden protection via secondary filings or new claims.
- Legal Preparedness: Regular patent validity, infringement, and freedom-to-operate analyses are critical for commercial success.
FAQs
1. How does KR20210111900 compare with other patents in its therapeutic area?
KR20210111900 likely covers a specific novel compound or formulation with claims tailored to differentiate from existing patents, with scope focused on unique structural features or use cases. Its strength depends on claim specificity and novelty over prior art.
2. What elements indicate the strength of a pharmaceutical patent like KR20210111900?
Claims that combine narrow, well-defined chemical structures with specific therapeutic methods tend to be stronger. Supporting disclosures, prior art analysis, and claim dependency also influence enforceability.
3. How important is patent landscape analysis in strategizing drug development in South Korea?
Critical. It helps identify freedom-to-operate, potential infringers, licensing opportunities, and areas requiring innovation to avoid patent infringement and strengthen market positions.
4. Can this patent be extended or reinforced?
Yes. Filing secondary or divisional applications, pursuing patent term extensions (if applicable under Korean law), and developing new claims around derivatives or new uses can strengthen and extend patent protection.
5. How does South Korea’s patent environment benefit pharmaceutical innovation?
South Korea’s robust patent laws, fast examination process, and active enforcement environment provide incentives for innovative R&D, helping companies secure exclusive rights and commercialize new medicines effectively.
References (Indicative)
[1] Korean Intellectual Property Office (KIPO). Patent Database.
[2] WIPO. Patent Cooperation Treaty (PCT) Application Database.
[3] McKinsey & Company. Global Pharmaceutical Patent Strategies.
[4] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
[5] Kim, M. et al., "Patent Strategies in the South Korean Pharmaceutical Sector," Intellectual Property Journal, 2022.
Disclaimer: The analysis is based on publicly available information and standard patent practices. For detailed legal opinions or proprietary insights, consultation with a patent attorney is recommended.
